Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill
Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss pill Wegovy.
MedPage Today on MSN
Novo Nordisk ends lawsuit, collaborates with Hims & Hers to sell semaglutide
Telehealth company will offer oral and injectable versions of the GLP-1 drug ...
Hosted on MSN
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
Novo Nordisk is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. The move ...
AOL
Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’
Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded ...
Yahoo
Novo Nordisk sues hims & hers over Ozempic, Wegovy knockoffs
Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk files suit against telehealth provider Hims & Hers, alleging unauthorized versions of Ozempic and Wegovy. The ...
NJBIZ
Hims & Hers pulls copycat Wegovy pill amid legal action
Hims & Hers reversed course on its launch of a cheaper, copycat version of Novo Nordisk’s GLP-1 weight loss pill amid legal action. In a Feb. 7 social media post, the San Francisco-based ...